The management team of Citigroup Inc. (C) received a positive review in an outside appraisal but some shuffling of senior executives could be on the anvil.

The review was conducted this summer for Citi’s board by recruiting and consulting firm Egon Zehnder International. It was triggered by the government’s stress tests on top banks. Companies found to be in need of additional capital were required to conduct assessments of their management and report the findings to federal regulators. The Federal Deposit Insurance Corp. (FDIC), which had concerns about the qualifications of Chief Executive Vikram Pandit and his top management team, required Citigroup to hire an outside firm to perform the review.

The report, delivered to Citigroup’s board on last Friday, gave strong overall marks to Citigroup’s management team and to CEO Vikram Pandit in particular.

The review, however, gave less-favorable reckonings to at least two of Pandit’s lieutenants, Vice Chairman Lewis Kaden and Chief Administrative Officer Don Callahan. Kaden’s responsibilities include Citigroup’s legal, human-resources and government-relations departments, while Callahan is in charge of the company’s operations and technology.

Citigroup’s board met on Tuesday morning to start discussing the findings and ways to respond to them. The company needs to inform the regulators this month about Egon Zehnder’s findings and how the board is responding to them. Options include removing certain executives and reassigning or clarifying their job responsibilities, but Citigroup directors could not come to a conclusion as yet.

The FDIC is likely to treat the management review as one factor in a broad assessment of Citigroup’s overall financial health. The report’s supportive spirit comes as a sharp contrast to the frustration building among some analysts, investors and Citigroup executives regarding Mr. Pandit’s leadership since he became CEO in December 2007. Mr. Pandit is known to overly rely on a small group of advisers.

The FDIC’s relationship with top Citigroup executives, especially Mr. Pandit and Vice Chairman Ned Kelly, has been callous since last year, when Citigroup’s plans for a government-assisted purchase of most of Wachovia Corp. fell apart.

Citigroup, once the largest U.S. bank by assets, fell behind last year after a series of acquisitions by rivals. The bank has been severely hurt by billions in losses and write-downs of problem loans and toxic assets.

The U.S. government injected $45 billion in bailout funds into the bank, $25 billion of which was recently converted to a 34% equity ownership stake. Top-level management at the company is conceiving plans to downsize the government’s stake in the company through a multibillion-dollar stock offering.

During the second quarter of 2009, Citigroup reported results separating the firm into Citicorp and Citi Holdings. The company is currently undergoing a major restructuring in its businesses and plans to hold down its assets and divest non-core businesses in Citi Holdings.

Citigroup will release its third quarter 2009 earnings on Oct. 15, 2009 with a conference call scheduled later in the day to discuss its results.

Ahead of its results, we maintain our Neutral recommendation on the stock.

Zacks Investment Research
View original at: Zacks.com News Feed

1. (C) Citigroup Exiting Smith BarneyCitigroup Inc.’s (C) Chief Executive Officer (CEO) Vikram Pandit indicated that the company will eventually...
2. (C) Citigroup Wins Lawsuit DismissalCitigroup Inc.’s (C) officers and directors (including Chief Executive Officer Vikram Pandit) won the dismissal...
3. (C) Bailed-Out Firms Under Pay Package ReviewThe U.S. pay czar, Kenneth Feinberg, has started a 60-day schedule to review the aptness...
4. (GSK) Glaxo Diet Drug Under FDA Safety ReviewWe are disappointed with the latest decision by the US Food and Drug Administration (FDA)...
5. (BMY) Bristol-Myers Squibb’s Plavix Patent Getting ReviewBristol-Myers Squibb (BMY) announced that its lead drug, Plavix, will be reviewed by the U.S....
6. (BMY) Bristol-Myers Squibb Co. announced Medarex Acquisition Cleared ReviewBristol-Myers Squibb Co. (BMY) yesterday announced that the regulatory review period for its cash tender...

Search Posts by Tag: C | Citigroup Inc. | Financial | Money Center Banks

RSS Feeds by Tag: C | Citigroup Inc. | Financial | Money Center Banks |

Other Posts by: vitalstocks | RSS Feed for this author